Article
Newer quinolones able to tackle many ocular surface bacteria
Stanford, CA-In vitro susceptibility test results demonstrate that the newer, 8-methoxy fluoroquinolones gatifloxacin (Zymar, Allergan) and moxifloxacin (Vigamox, Alcon) outperform older fluoroquinolones in their activity against gram-positive ocular isolates, including those with resistance to multiple other antibiotics, said Herminia Mi?o de Kaspar, PhD, senior research associate, department of ophthalmology, Stanford University, Stanford, CA.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
